PECBLOCK under echoguidance
ProcedurePerformance of block under echography
NCT Number: NCT01670448
Pain after breast cancer surgery could be severe and about 1/3 of patients will develop chronic pain. The PECBLOCK is the injection of local anesthetics between the two pectoral muscles to block pectoral nerves and intercostal nerves innervating the breast. The aim of this study is to evaluate the efficacy of the PECBLOCK performed under echoguidance in minor and major breast surgery. The prevention of chronic pain following surgery will also be evaluated.
Looking for future studies?
Notify Me18 year–85 year
Female
Interventional
Not applicable
CHUM, Montreal, Quebec, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Performance of block under echography
Time frame: 30 min after entering the recovery room or just before morphine administration if needed
Using a 0-10 verbal numerical scale where 0 is no pain and 10 the worst pain imaginable
Time frame: in the recovery room before discharge (after 1 h on average))
When surgery is over and the patient is brought to the recovery room, the total morphine consumption in mg used in the recovery (for pain less than 4/10) is recorded
Time frame: at the end of surgery (1-2 h on average)
When surgery is over, 1-2 h on average depending if it is a tumorectomy or a mastectomy, the total sufentanil consumption in micrograms during surgery is recorded.
Time frame: first 24 hours post surgery
Cardiovascular collapse, anaphylactic shock, hematoma, bleeding..?
Centre hospitalier de l'Université de Montréal (CHUM)
Other
The Pectoral Nerve Block (PECBLOCK) for the Treatment of Pain After Breast Cancer Surgery.
Acronym: PECBLOC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05869604
Behavior, Cancer
Durham, North Carolina, United States
View Trial DetailsNCT00646945
Cancer, Neoplasms
Vandœuvre-lès-Nancy, France
View Trial DetailsNCT02026115
Cancer, Neoplasms
View Trial DetailsNCT06508411
Cancer, Neoplasms
Clermont-Ferrand, France
View Trial Details